Evidence map›Paper›PMID 40642292›Full record

ArticleIBRO neuroscience reports2025

Uptakes of boronophenylalanine in the

Shining Zhang, Yujie Wei, Wenjiao Gu, Shuangyi Li, Ting Liu, Limei Shuai, Yu Tang, Ying Jiang, Xiaochun Zhou, Yucai Wei and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in IBRO neuroscience reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Shining ZhangCollege of Life Sciences and Biopharmaceuticals, Shenyang Pharmaceutical University, Shenyang 110016, China.
Yujie WeiGansu Province Key Laboratory of Environmental Oncology, Lanzhou University Second Hospital, Lanzhou 730030, China.
Wenjiao GuDepartment of Cardiovascular Disease, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou 730030, China.
Shuangyi LiDepartment of Cardiovascular Disease, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou 730030, China.
Ting LiuSchool of Basic Medical Sciences, Lanzhou University, Lanzhou 730030, China.
Limei ShuaiSchool of Basic Medical Sciences, Lanzhou University, Lanzhou 730030, China.
Yu TangClinical Medicine Department, Xinxiang Medical University, Xinxiang 453003, China.
Ying JiangDepartment of Cardiovascular Disease, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou 730030, China.
Xiaochun ZhouDepartment of Nephrology, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou 730030, China.
Yucai WeiGansu Province Key Laboratory of Environmental Oncology, Lanzhou University Second Hospital, Lanzhou 730030, China.
Guan WangSchool of Nuclear Science and Technology, Lanzhou University, Lanzhou, China.
Long GuSchool of Nuclear Science and Technology, Lanzhou University, Lanzhou, China.
Yumin LiGansu Province Key Laboratory of Environmental Oncology, Lanzhou University Second Hospital, Lanzhou 730030, China.
Futian TangGansu Province Key Laboratory of Environmental Oncology, Lanzhou University Second Hospital, Lanzhou 730030, China.
Daiying ZuoCollege of Life Sciences and Biopharmaceuticals, Shenyang Pharmaceutical University, Shenyang 110016, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human glioblastoma (GBM) is the most malignant brain tumor. Boron neutron capture therapy (BNCT) is proved to be a new technology for the effective treatment of GBM. We previously reported that boronophenylalanine (BPA), the boron drug used in BNCT prefers to the tumor of a mouse subcutaneous tumor model injected U87 and GL261, two GBM cell lines. The present study was designed to investigate the distribution of BPA in the tumor of a mouse

Indexed as

Boron distributionBoron neutron capture therapyBoronophenylalanineBrain tumor cell linesIn situ brain tumor model

Identifiers

PMID40642292
PMCPMC12241995

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.